Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05883371 · ClinicalTrials.gov registry record
IMPACT - AndHealth Autoimmune Research Registry
A clinical trial of Psoriasis and Arthritis, Rheumatoid, sponsored by AndHealth.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT05883371 is a study of Psoriasis and Arthritis, Rheumatoid that is actively recruiting participants, run by AndHealth. The registered enrollment target is 2,500 participants, above the 469-participant average among 125 other Psoriasis trials with a reported enrollment target (433% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05883371, a study of Psoriasis and Arthritis, Rheumatoid, is actively recruiting participants, sponsored by AndHealth.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a patient research registry aimed at evaluating the effectiveness of a comprehensive, root-cause medical approach ("AndHealth program") for autoimmune disorders. This approach involves a combination of pharmacological and non-pharmacological therapies offered under the care of a licensed physician with the support of health coaches. While protocol guidance is provided, the therapeutic approach is personalized to the individual needs of patients. The autoimmune disorders of focus in this registry include rheumatoid arthritis, psoriatic arthritis, psoriasis and ankylosing spondylitis. A variety of validated labs, patient-reported outcomes, and medication usage will be assessed among participating patients over a period of up to five years to evaluate the long-term effectiveness of this approach.
Conditions Studied
Interventions
- OTHER Root-cause autoimmune treatment program
Study Locations (1)
Ohio
- AndHealth - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2028-05-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05883371
The ClinicalTrials.gov registry entry for NCT05883371 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 469-participant average among 125 other Psoriasis trials with a reported enrollment target (433% higher). The listed sponsor is AndHealth, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Psoriasis appearing as the primary indexed condition, and to 1 intervention - of which Root-cause autoimmune treatment program is the first listed.
NCT05883371 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05883371 about?
NCT05883371 is a clinical study titled "IMPACT - AndHealth Autoimmune Research Registry". This is a patient research registry aimed at evaluating the effectiveness of a comprehensive, root-cause medical approach ("AndHealth program") for autoimmune disorders. This approach involves a combination of pharmacological and non-pharmacological therapies offered under the care of a licensed phy...
What is the current status of trial NCT05883371?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2023-06-08. Estimated completion is 2028-05-22.
What conditions does trial NCT05883371 study?
This clinical trial studies the following conditions: Psoriasis, Arthritis, Rheumatoid, Autoimmune Diseases, Arthritis, Psoriatic, Ankylosing Spondylitis.
What interventions are being tested in trial NCT05883371?
The interventions under investigation include: Root-cause autoimmune treatment program (OTHER).
Who is sponsoring clinical trial NCT05883371?
This trial is sponsored by AndHealth, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05883371 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psoriasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
RECRUITING · NA
-
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
-
Duobrii in Combination With Biologics
RECRUITING · Phase 4
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.